Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer.
Kusama M, Nomizu T, Aogi K, Yoshimoto M, Horikoshi N, Tabei T, Noguchi S, Miura S, Yoshimura N, Kimura M, Toyama K, Shin E.
Kusama M, et al. Among authors: kimura m.
Breast Cancer. 2010 Oct;17(4):233-40. doi: 10.1007/s12282-009-0137-5. Epub 2009 Jul 25.
Breast Cancer. 2010.
PMID: 19633909
Clinical Trial.